MENU
COR
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

COR stock forecast, quote, news & analysis

Cencora is one of three leading domestic pharmaceutical wholesalers... Show more

COR
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for COR with price predictions
Sep 11, 2026

Aroon Indicator for COR shows an upward move is likely

COR's Aroon Indicator triggered a bullish signal on September 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 346 similar instances where the Aroon Indicator showed a similar pattern. In 221 of the 346 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on September 11, 2026. You may want to consider a long position or call options on COR as a result. In 51 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

Following a +1.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where COR advanced for three days, in 238 of 384 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

Bearish Trend Analysis

The 10-day RSI Indicator for COR moved out of overbought territory on August 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 23 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 49%.

The Moving Average Convergence Divergence Histogram (MACD) for COR turned negative on September 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 23 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 44%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

COR broke above its upper Bollinger Band on September 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 14 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 27 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. COR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: COR's P/B Ratio (20.121) is slightly higher than the industry average of (7.715). P/E Ratio (23.873) is within average values for comparable stocks, (19.412). COR's Projected Growth (PEG Ratio) (0.673) is slightly lower than the industry average of (1.318). Dividend Yield (0.007) settles around the average of (0.007) among similar stocks. P/S Ratio (0.188) is also within normal values, averaging (4.328).

A.I.Advisor
published Dividends

COR paid dividends on August 31, 2026

Cencora COR Stock Dividends
А dividend of $0.60 per share was paid with a record date of August 31, 2026, and an ex-dividend date of August 14, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 20.87B. The market cap for tickers in the group ranges from 557.05K to 102.78B. MCK holds the highest valuation in this group at 102.78B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was -5%. For the same Industry, the average monthly price growth was -13%, and the average quarterly price growth was -32%. YI experienced the highest price growth at 2%, while AHG experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 109%. For the same stocks of the Industry, the average monthly volume growth was 33% and the average quarterly volume growth was 191%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 60
Price Growth Rating: 69
SMR Rating: 88
Profit Risk Rating: 74
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
COR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry MedicalDistributors

Profile
Details
Industry
Real Estate Investment Trusts
Address
1 West First Avenue
Phone
+1 610 727-7000
Employees
51000
Web
https://www.cencora.com
Aroon Indicator for COR shows an upward move is likely